紫杉醇器械用于外周动脉安全性的再评估

doi:10.16139/j.1007-9610.2019.04.006

摘要/Abstract

中图分类号:

R654.3

姚陈, 何榕洲. 紫杉醇器械用于外周动脉安全性的再评估[J]. 外科理论与实践, 2019, 24(04): 304-306.

[1] Schroeder H, Werner M, Meyer DR, et al.Low-dose paclitaxel-coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease: one-year results of the ILLUMENATE European randomized clinical trial (randomized trial of a novel paclitaxel-coated percutaneous angioplasty balloon)[J]. Circulation,2017,135(23):2227-2236.
[2] Ott I, Cassese S, Groha P, et al. ISAR-PEBIS (paclitaxe-leluting balloon versus conventional balloon angioplasty for in-stent restenosis of superficial femoral artery): a randomized trial[J]. J Am Heart Assoc,2017,6(7).pii: e006321.
[3] Ott I, Cassese S, Groha P, et al.Randomized comparison of paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease(ISAR-STATH)[J]. Circulation,2017, 135(23):2218-2226.
[4] Krishnan P, Faries P, Niazi K, et al.Stellarex drug-coa-ted balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies[J]. Circulation,2017,136(12):1102-1113.
[5] Kinstner CM, Lammer J, Willfort-Ehringer A, et al.Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial[J]. JACC Cardiovasc Interv,2016,9(13):1386-1392.
[6] Jia X, Zhang J, Zhuang B, et al.Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the Aco-Art Ⅰ trial[J]. JACC Cardiovasc Interv,2016,9(18):1941-1949.
[7] Tepe G, Laird J, Schneider P, et al.Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peri-pheral artery disease 12-month results from the IN. PACT SFA randomized trial[J]. Circulation,2015,131(5):495-502.
[8] Scheinert D, Duda S, Zeller T, et al.The LEVANT Ⅰ (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty[J]. JACC Cardiovasc Interv,2014,7(1):10-19.
[9] Liistro F, Grotti S, Porto I, et al.Drug-eluting balloon in peripheral intervention for the superficial femoral artery The DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)[J]. JACC Cardiovasc Interv,2013,6(12):1295-1302.
[10] Tepe G, Zeller T, Albrecht T, et al.Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg[J]. N Engl J Med,2008,358(7):689-699.
[11] Ohki T, Yokoi H, Kichikawa K, et al.Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational cli-nical trials[J]. J Endovasc Ther,2014,21(5):644-653.
[12] Katsanos K, Spiliopoulos S, Kitrou P, et al.Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systema-tic review and meta-analysis of randomized controlled trials[J]. J Am Heart Assoc,2018,7(24):e011245.
[13] Schneider PA, Laird JR, Doros G, et al.Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon[J]. J Am Coll Cardiol,2019,73(20):2550-2563.
[14] Secemsky EA, Kundi H, Weinberg I, et al.Association of survival with femoropopliteal artery revascularization with drug-coated devices[J]. JAMA Cardiol,2019.doi:10.1001
[15] Guo W. New DCB era for BTK: 6-months results from the China AcoArt Ⅱ Study. LINC2019. Leipzig, Germany[EB/OL].[2019-07-08]. https://linc2019.cncptdlx.com/media/0830_Wei_Guo_23_01_2019_Room_1_-_Main_Arena_1.pdf.
[16] Binder S. Evolution of taxanes in the treatment of metastatic breast cancer[J]. Clin J Oncol Nurs,2013,17 Suppl:9-14.
[17] TAXOL (paclitaxel) Injection Warnings and Safety Information. Bristol Myers-Squibb2011[EB/OL].[2019-07-08]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020262s049lbl.pdf.
[18] Otsuka F, Vorpahl M, Nakano M, et al.Pathology of se-cond-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans[J]. Circulation,2014,129(2):211-223.
[19] Duda SH, Bosiers M, Lammer J, et al.Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial[J]. J Endovasc Ther,2006,13(6):701-710.
[20] Duda SH, Bosiers M, Lammer J, et al.Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO Ⅱ trial[J]. J Vasc Interv Radiol,2005,16(3):331-338.
[21] Zeller T, Baumgartner I, Scheinert D, et al.Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial[J]. J Am Coll Cardiol,2014,64(15):1568-1576.

紫杉醇器械用于外周动脉安全性的再评估

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	董继英　陆文婷　姚姗姗　王棽　严敏　陆茅丹　朱婕　温晓钰　姚敏. 冷冻溶脂技术治疗亚洲人群皮下局部脂肪堆积的效果[J]. 组织工程与重建外科杂志, 2022, 18(3): 252-.
[2]	董继英　吴珊　王棽　严敏　米晶　林琥燕　曾颖　张逸秋　宋晨璐　裴庆　朱婕　温晓钰　陆文婷　姚敏. 光电治疗对皮肤创伤性瘢痕的疗效研究[J]. 组织工程与重建外科杂志, 2022, 18(2): 133-.
[3]	杨辰, 颜国正, 周泽润, 华芳芳. 人造肛门括约肌经皮无线供能系统安全性及相容性分析[J]. 上海交通大学学报, 2021, 55(9): 1151-1157.
[4]	杨中印, 李琛, 刘文韬, 施敏, 吴珺玮, 郑亚南, 朱正伦, 华子辰, 倪震天, 陆晟, 燕敏, 严超, 朱正纲. 胃癌腹膜转移病人腹腔化疗港并发症发生及危险因素分析[J]. 外科理论与实践, 2021, 26(01): 41-47.
[5]	赵艳娜, 柳俊, 黄莉, 徐文娟, 聂子淮, 费健, 顾建华. 生理盐水隔离带在激光、射频和微波甲状腺热消融术中安全性的实验研究[J]. 外科理论与实践, 2020, 25(05): 432-436.
[6]	姜松耀, 赵良超, 严晓伟, 胡皆乐, 项明. 紫杉醇腹腔热灌注联合静脉化疗转化治疗晚期胃癌(附1例报告)[J]. 外科理论与实践, 2020, 25(02): 152-154.
[7]	孙步豪，沈卫民. 西罗莫司治疗脉管畸形的研究进展[J]. 组织工程与重建外科杂志, 2019, 15(4): 263-265.
[8]	牛思杰;黄伟;姜鑫;全威;郭秋红;. 基于析因设计的轻卡正面碰撞安全性优化[J]. 机械设计与研究, 2019, 35(05): 194-200+205.
[9]	莫志敏;黄伟;郭秋红;全威;姜鑫;. 基于薄壁梁压溃理论的商用车被动安全性提升研究[J]. 机械设计与研究, 2019, 35(03): 168-172.
[10]	蔡源源，靖昌瑞，李永忠. 点阵激光在面部年轻化中的疗效及安全性[J]. 组织工程与重建外科杂志, 2018, 14(5): 277-279.
[11]	叶颖江, 高志冬. 在争议中前行：完全结肠系膜切除术的安全性与有效性[J]. 外科理论与实践, 2018, 23(05): 405-408.
[12]	王少杰1,3，徐赵东1，刘福胜2，李舒1，DYKE S J3. 简支梁桥竖向线形变化对双线对开轻轨列车运行性能的影响[J]. 上海交通大学学报（自然版）, 2017, 51(3): 359-.
[13]	梁贇, 姜翀弋, 王巍,. 胰腺癌的靶向治疗[J]. 外科理论与实践, 2017, 22(01): 84-88.
[14]	周佳，王健，余力，张波，郑丹宁，李青峰. L形高密度聚乙烯材料用于短鼻延长术的安全性研究[J]. 组织工程与重建外科杂志, 2016, 12(2): 114-116.
[15]	赵建轩;朱平;刘钊;王增伟;. 考虑NVH性能与碰撞安全性的轿车车身轻量化设计[J]. 机械设计与研究, 2016, 32(06): 153-157+160.